Global Recombinant DNA Vaccine Market Research Report 2021

1 Recombinant DNA Vaccine Market Overview

• 1.1 Product Overview and Scope of Recombinant DNA Vaccine
• 1.2 Recombinant DNA Vaccine Segment by Type
  • 1.2.1 Global Recombinant DNA Vaccine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Recombinant Protein Vaccine
  • 1.2.3 Gene-Based Vaccine
• 1.3 Recombinant DNA Vaccine Segment by Application
  • 1.3.1 Recombinant DNA Vaccine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Human
  • 1.3.3 Animal
• 1.4 Global Recombinant DNA Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Recombinant DNA Vaccine Revenue 2016-2027
  • 1.4.2 Global Recombinant DNA Vaccine Sales 2016-2027
  • 1.4.3 Recombinant DNA Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Recombinant DNA Vaccine Market Competition by Manufacturers

• 2.1 Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Recombinant DNA Vaccine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Recombinant DNA Vaccine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Recombinant DNA Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Recombinant DNA Vaccine Market Competitive Situation and Trends
  • 2.5.1 Recombinant DNA Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Recombinant DNA Vaccine Players Market Share by Revenue
  • 2.5.3 Global Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant DNA Vaccine Retrospective Market Scenario by Region

• 3.1 Global Recombinant DNA Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Recombinant DNA Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Recombinant DNA Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Recombinant DNA Vaccine Sales by Country
  • 3.3.2 North America Recombinant DNA Vaccine Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Recombinant DNA Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Recombinant DNA Vaccine Sales by Country
  • 3.4.2 Europe Recombinant DNA Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Recombinant DNA Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Recombinant DNA Vaccine Sales by Region
  • 3.5.2 Asia Pacific Recombinant DNA Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Recombinant DNA Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Recombinant DNA Vaccine Sales by Country
  • 3.6.2 Latin America Recombinant DNA Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Recombinant DNA Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Recombinant DNA Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Recombinant DNA Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Recombinant DNA Vaccine Historic Market Analysis by Type

• 4.1 Global Recombinant DNA Vaccine Sales Market Share by Type (2016-2021)
• 4.2 Global Recombinant DNA Vaccine Revenue Market Share by Type (2016-2021)
• 4.3 Global Recombinant DNA Vaccine Price by Type (2016-2021)

5 Global Recombinant DNA Vaccine Historic Market Analysis by Application

• 5.1 Global Recombinant DNA Vaccine Sales Market Share by Application (2016-2021)
• 5.2 Global Recombinant DNA Vaccine Revenue Market Share by Application (2016-2021)
• 5.3 Global Recombinant DNA Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Merck
  • 6.1.1 Merck Corporation Information
  • 6.1.2 Merck Description and Business Overview
  • 6.1.3 Merck Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Merck Product Portfolio
  • 6.1.5 Merck Recent Developments/Updates
• 6.2 GSK
  • 6.2.1 GSK Corporation Information
  • 6.2.2 GSK Description and Business Overview
  • 6.2.3 GSK Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 GSK Product Portfolio
  • 6.2.5 GSK Recent Developments/Updates
• 6.3 Sanofi
  • 6.3.1 Sanofi Corporation Information
  • 6.3.2 Sanofi Description and Business Overview
  • 6.3.3 Sanofi Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Sanofi Product Portfolio
  • 6.3.5 Sanofi Recent Developments/Updates
• 6.4 Zoties
  • 6.4.1 Zoties Corporation Information
  • 6.4.2 Zoties Description and Business Overview
  • 6.4.3 Zoties Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Zoties Product Portfolio
  • 6.4.5 Zoties Recent Developments/Updates
• 6.5 Elanco
  • 6.5.1 Elanco Corporation Information
  • 6.5.2 Elanco Description and Business Overview
  • 6.5.3 Elanco Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Elanco Product Portfolio
  • 6.5.5 Elanco Recent Developments/Updates
• 6.6 Boehringer-Ingelheim
  • 6.6.1 Boehringer-Ingelheim Corporation Information
  • 6.6.2 Boehringer-Ingelheim Description and Business Overview
  • 6.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Boehringer-Ingelheim Product Portfolio
  • 6.6.5 Boehringer-Ingelheim Recent Developments/Updates
• 6.7 Indian Immunologicals
  • 6.6.1 Indian Immunologicals Corporation Information
  • 6.6.2 Indian Immunologicals Description and Business Overview
  • 6.6.3 Indian Immunologicals Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Indian Immunologicals Product Portfolio
  • 6.7.5 Indian Immunologicals Recent Developments/Updates
• 6.8 Plumbline Life Sciences
  • 6.8.1 Plumbline Life Sciences Corporation Information
  • 6.8.2 Plumbline Life Sciences Description and Business Overview
  • 6.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Plumbline Life Sciences Product Portfolio
  • 6.8.5 Plumbline Life Sciences Recent Developments/Updates

7 Recombinant DNA Vaccine Manufacturing Cost Analysis

• 7.1 Recombinant DNA Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Recombinant DNA Vaccine
• 7.4 Recombinant DNA Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Recombinant DNA Vaccine Distributors List
• 8.3 Recombinant DNA Vaccine Customers

9 Recombinant DNA Vaccine Market Dynamics

• 9.1 Recombinant DNA Vaccine Industry Trends
• 9.2 Recombinant DNA Vaccine Growth Drivers
• 9.3 Recombinant DNA Vaccine Market Challenges
• 9.4 Recombinant DNA Vaccine Market Restraints

10 Global Market Forecast

• 10.1 Recombinant DNA Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Recombinant DNA Vaccine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Type (2022-2027)
• 10.2 Recombinant DNA Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Recombinant DNA Vaccine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Application (2022-2027)
• 10.3 Recombinant DNA Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Recombinant DNA Vaccine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Recombinant DNA Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List